Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reteplase vs Alteplase in Acute Ischemic Stroke
NCT04028518Phase 2Unknown
- Sponsor
- China Resources Angde Biopharmaceutical
- Start
- Jul 2019
- Primary completion
- Oct 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of reteplase in ischemic stroke, sponsored by China Resources Angde Biopharmaceutical. Status: unknown.
02
Drugs
reteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04028518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028518.